Capecitabine plus oxaliplatin vs infusional 5-fluorouracil plus oxaliplatin in the treatment of colorectal cancer. Con: Pumpin' FU (or, avoiding that oral fixation).
Hochster
Howard S
HS
New York University Cancer Center, New York, NY 10016, USA.
D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage* / Q000191:economics / Q000592:standards; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage* / Q000191:economics / Q000592:standards; D000069287:Capecitabine; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000191:economics; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000191:economics / Q000592:standards / Q000633:toxicity; D005472:Fluorouracil / Q000008:administration & dosage* / Q000191:economics / Q000592:standards; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage / Q000191:economics / Q000592:standards; D009944:Organoplatinum Compounds / Q000008:administration & dosage / Q000191:economics / Q000592:standards; D000077150:Oxaliplatin; D016032:Randomized Controlled Trials as Topic
D000964:Antimetabolites, Antineoplastic; D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D003841:Deoxycytidine; D000069287:Capecitabine; D002955:Leucovorin; D005472:Fluorouracil